With a vaccine sector valued at ~INR 95 billion and growing at a CAGR of 18%, India is a global leader in vaccine manufacturing and production. Established in 1978, India’s Universal Vaccination Programme (UIP) is the World’s largest public vaccination program, and provides twelve free vaccines against critical diseases to nearly 56 million children and pregnant women annually. The UIP’s concerted efforts over nearly four decades have resulted in gradually increasing vaccine coverage, reaching 62% vaccination coverage with the government’s ‘Mission Indradhanush’ expected to accelerate the increase in vaccine coverage. However, will this infrastructure and capacity be able to provide the ambitious 600M doses of COVID-19 vaccine planned by July 31st? What role is the private sector currently playing and looking to play in this campaign rollout? These are some of the questions we attempt to answer in this report.

To understand this better, IDFC Institute partnered with Pharmarack Technologies Pvt. Ltd., a B2B healthcare service provider to unpack and assess India’s COVID-19 vaccine distribution capacity and preparedness (both private and public sector), including – vaccine equipment capacities, cold storage capacities, transport and logistical preparedness and state level disparities in their readiness to roll-out the campaign. We did this through extensive secondary research, interviews with top vaccine manufacturers, vaccine transportation and logistics companies, nonprofits and multilateral organisations, FMCG companies involved in cold-chain transport and storage and subject matter experts.

 

This work was done by the author/s when they were a part of the IDFC Institute and is republished here with permission.